| Sustaining competitive advantage within the | | | | MaltesePoland - PolishRomania - RomanianSlovakia |
| medical device industry involves a global product | | | | - SlovakSlovenia - SlovenianTurkey - TurkishEU |
| strategy that recognizes the European market's | | | | Member State Official Languages |
| substantial global market share. Estimated at 30% | | | | Depending on the extent of the product's |
| of the global medical device market, the European | | | | presence in the European Union, there are |
| community poses increasing regulatory challenges | | | | currently up to 12 languages required for the |
| for medical device manufacturers. Regulations | | | | labeling, IFUs, documentation, and marketing |
| controlling the manufacturing, marketing and usage | | | | materials in accordance with the IVDD and MDD |
| of medical devices in the EU are forcing | | | | necessary for CE mark as displayed in TABLE I |
| manufacturers to incorporate language translation | | | | .As the EU continues to grow and the trading |
| and localization into global development strategies | | | | barriers dissolve, prospective Member States are |
| as individual Member States demand product | | | | actively transitioning regulations to meet the CE |
| information in the language of the local user.An | | | | mark criteria, requiring new languages. A midday |
| exigent regulatory hurdle facing the medical device | | | | regulatory shadow to the EU, European Free |
| industry is the European Union's IVDD 98/79/EC | | | | Trade Association (EFTA) countries of Iceland, |
| directive which went into effect December 7, | | | | Liechtenstein and Norway are aggressively |
| 2003. Formulated five years ago, the IVDD 98/79 | | | | enforcing the CE mark, shown in TABLE II . |
| EC dictates that as of the December date, all | | | | Although not a member of the EFTA, Switzerland |
| new in vitro medical devices must bear CE Marks | | | | is also enforcing medical device CE mark.In |
| or face refusal into the European market or | | | | addition to the EFTA, 13 more countries have |
| regulatory, criminal or product/civil liability.What is | | | | applied for membership in the European Union. |
| the guiding principle behind the new directive?The | | | | Performing a parallel migration to the European |
| IVDD Directive virtually eliminates the costly | | | | Union's regulatory requirements, several of these |
| regulations imposed by individual member states. | | | | future Member States are actively adopting the |
| Manufacturers who comply with the Directive will | | | | CE Mark to ensure goods can freely move |
| be able to apply the CE mark to their products | | | | throughout the European Union, including Poland, |
| and market them freely within member states of | | | | Romania, Slovakia, and Turkey, seeTABLE III . |
| the EU. | | | | Global Harmonization and International Quality |
| The IVDD (In Vitro Diagnostic Devices Directive) | | | | Standards |
| is one of three associated directives issued by the | | | | In 1998, the United States and the European |
| European Union, which together cover all forms of | | | | Union introduced the New Transatlantic |
| medical equipment with the intent to ensure that | | | | Agreement (NTA) to improve economic |
| only safe and effective products are sold in the | | | | cooperation between the two economic powers. |
| European market. The directives clearly outline | | | | In this landmark accord resides the Mutual |
| regulations regarding manufacturing, importing, and | | | | Recognition Agreement (MRA) that acknowledges |
| marketing of such devices. The IVDD specifically | | | | the regulatory standards of the respective |
| involves in vitro ( in an artificial environment | | | | economic bodies-an area of transition that affects |
| outside the living organism ) medical devices that | | | | the medical device industry. The European Union |
| examine human fluids or tissue samples to | | | | medical device directives refer to ISO 9001 as |
| identify, diagnose, and monitor medical conditions. | | | | the series of quality management standards and |
| The IVDD 98/79/EC brings in vitro devices in line | | | | the US refers to FDA's Quality System |
| with other medical devices already regulated by | | | | Requirements and all corresponding good |
| the EU, the MDD (Medical Devices Directive) and | | | | manufacturing (GMP) practices regulations. |
| the AIMDD (Active Implantable Medical Devices | | | | Benefiting medical and pharmaceutical companies, |
| Directive).The IVDD and it sibling directives apply | | | | both quality systems have made considerable |
| progressive regulatory requirements to medical | | | | efforts to synchronize their requirements further |
| devices and their accessories depending on the | | | | increasing the common ground between quality |
| classified risk they present to the user, defined in | | | | systems in North America and Europe.ISO |
| the directive as Class I through III. Unless the | | | | (International Organization for Standardization) |
| classified product is a low-risk Class I device that | | | | Adding to the pressure the current ISO |
| does not contain any sterile packaging or a | | | | 9000:1994 standard is transitioning to a new ISO: |
| measuring function, manufacturers require a | | | | 9000:2000 series effective December 14th of this |
| third-party Notified Body to independently certify | | | | year. However, as of May 15, 2003, only 19.5% |
| the device's compliance to the Directive's Essential | | | | of the total ISO registered North American |
| Requirements (a.k.a. Annex I)-good faith is not | | | | companies had completed their registration |
| enough. Additionally, in a new twist within the | | | | process. This is essential in the entire chain of |
| Directive, the authorized representative shown on | | | | requirements. The new standard is a consolidation |
| the device label for Class I devices manufactured | | | | of ISO 9001 and 9002, and has more of a |
| outside the EU may be required to produce the | | | | customer satisfaction and continuous |
| technical file, including copies of all translated | | | | improvement focus not present in previous |
| materials. Any incorrect labeling or instructions for | | | | versions.GMP (Good Manufacturing Practices) |
| use may lead to regulatory criminal or product | | | | In December 1978, the FDA Good Manufacturing |
| civil liability in the EU.Any medical device | | | | Practices (GMP) Regulation became effective, |
| manufacturer wishing to market its products in | | | | establishing Quality System Requirements for |
| the European Union is fully responsible for | | | | products regulated under the FDA, including |
| complying with the corresponding safety and | | | | medical devices. In 1990, the Safe Medical Devices |
| administrative Essential Requirements and must | | | | Act (SMDA) expanded the GMP to include design, |
| display the CE mark of conformity as stated in | | | | manufacturing, packaging, labeling, storage, |
| Article 16 of the IVDD 98/79/EC . If that's not a | | | | installation and servicing of all finished medical |
| red flag, consider the next regulatory deadline | | | | devices.Exporting American Medical Devices |
| facing in vitro device manufacturers: By | | | | Any medical device in the US market may not |
| December 7, 2005, the European Union will not | | | | be legally exported anywhere in the world without |
| only require a CE mark to legally market a | | | | prior FDA notification or approval; however, for a |
| product, but will require a CE mark to legally put a | | | | device to be legally distributed in the US, the FDA |
| medical device into service-a requirement much | | | | requires: |
| more critical to the revenue of manufacturers | | | | Registration of both the medical device and |
| and healthcare!CE Mark: A passport to the | | | | manufacturing site- Authorization for commercial |
| European Union | | | | distribution through either a 510(k) pre-market |
| An abbreviation of a French phase "Conformite | | | | notification or a Pre-market Approval (PMA) |
| Europeene," the CE mark indicates that the | | | | application depending upon the classification of the |
| medical device manufacturer has conformed to all | | | | device- Compliance with FDA labeling |
| the obligations set forth by the Directive 98/79 | | | | requirements- Manufacturing compliance with the |
| EC of the European Parliament. Affixing this | | | | FDA's GoodManufacturing Practices (GMP)While |
| multinational standardized mark to a product will | | | | the FDA does not place any restrictions on the |
| allow any global manufacturer a "passport" to | | | | export of these devices, certain countries require |
| freely distribute their products within the European | | | | an Export Certificate that the manufacturer and |
| Union without additional quality testing or | | | | its devices are indeed in compliance with FDA |
| approvals. Reflective of the 1946 Treaty of | | | | regulations. Medical devices that do not have a |
| Rome, the CE mark is a conformity tool that is | | | | 510(k), PMA, or are solely manufactured for |
| intended to further promote the establishment of | | | | export may by approved for exportation by the |
| a single market where the free movement of | | | | FDA through Section 801(e)(1) of the FFDCA; |
| goods, persons, services and capital are ensured. | | | | however, the manufacturer may experience |
| Fundamentally, the CE mark and the medical | | | | regulatory difficulties depending on the individual |
| device directives remove many regulatory hurdles | | | | country's requirements of an FDA Export |
| while providing stronger regulations for smaller | | | | Certificate, which, as stated above, require a 510 |
| countries; however, it also creates critical language | | | | (k) or a PMA.Sorting through the regulations to |
| compliance issues that may prove to be costly | | | | achieve global product delivery |
| for manufacturers. Regardless of the intended | | | | The question facing medical device |
| global harmonization, participating countries are | | | | manufacturers in the current global market is how |
| preserving their national cultures and languages by | | | | to meet all language requirements in the most |
| requiring product information in their own local | | | | cost-effective, regulatory compliant manner. |
| languages.IVDD, MDD & AIMD...more languages! | | | | Managing regulations and translations are among |
| Depending on device classification, to legally | | | | the most critical aspects of developing and |
| display the CE mark, the IVDD, MDD, and AIMD | | | | marketing products for the life sciences industries. |
| all mandate that manufacturers provide all labeling, | | | | Any mistake, no matter how minor, can delay |
| information for usage, documentation, and | | | | product approvals, launches, or cause widespread |
| marketing materials in the official language(s) of | | | | public relations disasters. Therefore, developing |
| the end-user's Member State, taking into account | | | | translation and localization processes has become |
| the training and knowledge of the potential users | | | | a competitive advantage for global manufacturers |
| as stated in Article 4, Paragraph 4, IVDD 98/79 | | | | of medical devices.Working closely with a |
| EC .Documentation Translation Requirements - | | | | translation and localization vendor who specializes |
| Conformity Assessment Procedures | | | | in medical language services is an important step |
| Manufacturers are required to translate the | | | | in conquering the ever-changing international |
| documentation relating to the production, testing | | | | regulatory process. The choice of the translation |
| and quality processes in the official language(s) of | | | | provider is extremely important to ensure that |
| the Member State in which the procedures are | | | | translations are accurate, consistent and |
| carried out as stated in Article 9, Paragraph 11 of | | | | technically correct, as well as harmonious with the |
| the IVDD 98/79/EC. Depending on device | | | | manufacturers' processes.Medical language service |
| classification, these documents must include a | | | | providers should-at the very least-provide |
| number of required disclosures dependent on the | | | | documented processes that involve |
| product classification. | | | | native-speaking linguists that have expertise in |
| Depending on marketing and distribution | | | | both medical translation and the medical industry. |
| objectives, some products may require up to 12 | | | | To deliver consistency, quality and reduced costs, |
| languages, creating complicated multilingual product | | | | the language service provider should also |
| labeling and IFU challenges. There can be over 20 | | | | implement terminology management tools and |
| information pieces required for each product label | | | | computer-assisted translation solutions in concert |
| of IFU, depending on the classification as detailed | | | | with the team of human translators.Conclusion |
| in Annex I, Part B, Section 8 of the | | | | Complex and ever-changing international |
| Directive.Table I | | | | regulations controlling the marketing and usage of |
| Official Language(s) of EU Member | | | | medical devices are forcing manufacturers to |
| StatesMember State Official language(s)Austria - | | | | incorporate language translation and localization into |
| GermanBelgium - Dutch, French & | | | | global development strategies. The European Union |
| GermanDenmark - DanishFinland - FinnishFrance - | | | | members currently require that all product |
| FrenchGermany - GermanGreece - GreekIreland - | | | | information be in the official language of the local |
| EnglishItaly - ItalianLuxembourg - French, German, | | | | users and the diversity of this economic area is |
| LuxembourgishNetherlands - DutchPortugal - | | | | only growing to include more regulations and |
| PortugueseSpain - SpanishSweden - | | | | official languages. A simultaneous global release of |
| SwedishUnited Kingdom - EnglishTable II | | | | medical devices involving up to 12 languages in |
| Official Language(s) of EFTA Member States | | | | Europe alone makes this issue as critical as the |
| Member State Official language(s)Iceland - | | | | intended purpose of the medical device. |
| IcelandicLiechtenstein - GermanNorway - | | | | Medical device manufacturers can |
| NorwegianSwitzerland - German, French & Italian( | | | | cost-effectively market their products globally |
| Switzerland is not a EFTA member but requires | | | | while satisfying international regulatory |
| translation)Table III | | | | requirements by partnering with Net-Translators a |
| Official Language(s) of Member States Applying | | | | qualified language service provider in the very |
| For EU Membership | | | | early stages of product development. The right |
| Member State Official language(s) Bulgaria - | | | | language partner can turn what may now appear |
| BulgarianCyprus - GreekCzech Republic - | | | | as a chaos of regulatory requirements into a |
| CzechEstonia - EstonianHungary - HungarianLatvia | | | | successful international product release. |
| - LatvianLithuania - LithuanianMalta - English & | | | | |